A detailed history of Concourse Financial Group Securities, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 54,201 shares of PFE stock, worth $1.45 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
54,201
Previous 46,835 15.73%
Holding current value
$1.45 Million
Previous $1.31 Million 19.69%
% of portfolio
0.1%
Previous 0.08%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$27.7 - $31.39 $204,038 - $231,218
7,366 Added 15.73%
54,201 $1.57 Million
Q2 2024

Jul 23, 2024

BUY
$25.26 - $29.6 $9,320 - $10,922
369 Added 0.79%
46,835 $1.31 Million
Q1 2024

Apr 30, 2024

BUY
$25.89 - $29.73 $124,349 - $142,793
4,803 Added 11.53%
46,466 $1.29 Million
Q4 2023

Feb 07, 2024

SELL
$26.13 - $33.94 $407,523 - $529,328
-15,596 Reduced 27.24%
41,663 $1.2 Million
Q3 2023

Oct 25, 2023

SELL
$32.09 - $37.51 $2,984 - $3,488
-93 Reduced 0.16%
57,259 $1.9 Million
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $31,604 - $36,566
875 Added 1.55%
57,352 $2.1 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $60,503 - $78,766
-1,536 Reduced 2.65%
56,477 $2.3 Million
Q4 2022

Jan 30, 2023

SELL
$41.75 - $54.5 $127,546 - $166,497
-3,055 Reduced 5.0%
58,013 $0
Q3 2022

Nov 15, 2022

BUY
$43.76 - $53.42 $291,179 - $355,456
6,654 Added 12.23%
61,068 $2.67 Million
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $28,336 - $33,598
-609 Reduced 1.11%
54,414 $2.85 Million
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $799,298 - $990,430
-17,471 Reduced 24.1%
55,023 $2.85 Million
Q4 2021

Feb 07, 2022

SELL
$41.32 - $61.25 $681,284 - $1.01 Million
-16,488 Reduced 18.53%
72,494 $4.28 Million
Q3 2021

Nov 09, 2021

SELL
$39.25 - $50.42 $96,123 - $123,478
-2,449 Reduced 2.68%
88,982 $3.83 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $171,003 - $193,718
4,762 Added 5.49%
91,431 $3.58 Million
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $24,481 - $27,609
-731 Reduced 0.84%
86,669 $3.14 Million
Q4 2020

Feb 02, 2021

BUY
$33.47 - $42.56 $262,739 - $334,096
7,850 Added 9.87%
87,400 $3.22 Million
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $328,930 - $385,910
10,360 Added 14.97%
79,550 $2.92 Million
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $229,213 - $278,069
7,610 Added 12.36%
69,190 $2.26 Million
Q1 2020

May 13, 2020

BUY
$27.03 - $38.62 $165,747 - $236,817
6,132 Added 11.06%
61,580 $2.01 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $921,760 - $1.05 Million
28,000 Added 102.01%
55,448 $2.17 Million
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $853,967 - $1.11 Million
-26,284 Reduced 48.92%
27,448 $986,000
Q2 2019

Aug 13, 2019

BUY
$36.98 - $41.52 $509,140 - $571,647
13,768 Added 34.45%
53,732 $2.33 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $606,187 - $665,998
-16,165 Reduced 28.8%
39,964 $1.7 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $1.67 Million - $1.91 Million
43,453 Added 342.8%
56,129 $2.45 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $436,941 - $529,983
12,676 New
12,676 $559,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.